AP
Appleton Partners’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-910
| Closed | -$255K | – | 287 |
|
|
2021
Q1 | $255K | Sell |
910
-104
| -10% | -$29.1K | 0.02% | 258 |
|
|
2020
Q4 | $248K | Buy |
+1,014
| New | +$248K | 0.02% | 249 |
|
|
2020
Q2 | – | Sell |
-833
| Closed | -$264K | – | 259 |
|
|
2020
Q1 | $264K | Sell |
833
-150
| -15% | -$47.5K | 0.04% | 225 |
|
|
2019
Q4 | $292K | Buy |
+983
| New | +$292K | 0.03% | 243 |
|
|
2019
Q2 | – | Sell |
-948
| Closed | -$224K | – | 280 |
|
|
2019
Q1 | $224K | Hold |
948
| – | – | 0.03% | 249 |
|
|
2018
Q4 | $285K | Sell |
948
-2,447
| -72% | -$736K | 0.04% | 219 |
|
|
2018
Q3 | $1.2M | Sell |
3,395
-7
| -0.2% | -$2.47K | 0.16% | 129 |
|
|
2018
Q2 | $987K | Sell |
3,402
-74
| -2% | -$21.5K | 0.14% | 143 |
|
|
2018
Q1 | $952K | Buy |
3,476
+94
| +3% | +$25.7K | 0.14% | 144 |
|
|
2017
Q4 | $1.08M | Buy |
3,382
+13
| +0.4% | +$4.14K | 0.17% | 133 |
|
|
2017
Q3 | $1.06M | Sell |
3,369
-2,355
| -41% | -$737K | 0.18% | 128 |
|
|
2017
Q2 | $1.55M | Buy |
5,724
+2,334
| +69% | +$633K | 0.26% | 95 |
|
|
2017
Q1 | $927K | Sell |
3,390
-2,484
| -42% | -$679K | 0.17% | 124 |
|
|
2016
Q4 | $1.67M | Sell |
5,874
-210
| -3% | -$59.6K | 0.34% | 81 |
|
|
2016
Q3 | $1.9M | Buy |
6,084
+2,112
| +53% | +$661K | 0.36% | 76 |
|
|
2016
Q2 | $961K | Sell |
3,972
-321
| -7% | -$77.7K | 0.2% | 104 |
|
|
2016
Q1 | $1.12M | Sell |
4,293
-311
| -7% | -$81K | 0.22% | 91 |
|
|
2015
Q4 | $1.41M | Buy |
4,604
+523
| +13% | +$160K | 0.28% | 82 |
|
|
2015
Q3 | $1.19M | Sell |
4,081
-5,416
| -57% | -$1.58M | 0.27% | 86 |
|
|
2015
Q2 | $3.84M | Buy |
9,497
+226
| +2% | +$91.3K | 0.86% | 43 |
|
|
2015
Q1 | $3.92M | Buy |
+9,271
| New | +$3.92M | 0.88% | 41 |
|
|
2014
Q2 | – | Sell |
-771
| Closed | -$236K | – | 177 |
|
|
2014
Q1 | $236K | Buy |
+771
| New | +$236K | 0.06% | 162 |
|